RESUMO
Hyaluronan (HA), a negatively charged linear glycosaminoglycan, is a key macromolecular component of the articular cartilage extracellular matrix. The differential effects of HA are determined by a spatially/temporally regulated display of HA receptors, such as CD44 and receptor for hyaluronan-mediated motility (RHAMM). HA signaling through CD44 with RHAMM has been shown to stimulate inflammation and fibrotic processes. This study shows an increased expression of RHAMM in proinflammatory macrophages. Interfering with HA/RHAMM interactions using a 15-mer RHAMM-mimetic, HA-binding peptide, together with high-molecular-weight (HMW) HA reduced the expression and release of inflammatory markers and increased the expression of anti-inflammatory markers in proinflammatory macrophages. HA/RHAMM interactions were interfered in vivo during the regeneration of a full-thickness cartilage defect after microfracture surgery in rabbits using three intra-articular injections of 15-mer RHAMM-mimetic. HA-binding peptide together with HMWHA reduced the number of proinflammatory macrophages and increased the number of anti-inflammatory macrophages in the injured knee joint and greatly improved the repair of the cartilage defect compared with intra-articular injections of HMWHA alone. These findings suggest that HA/RHAMM interactions play a key role in cartilage repair/regeneration via stimulating inflammatory and fibrotic events, including increasing the ratio of proinflammatory/anti-inflammatory macrophages. Interfering with these interactions reduced inflammation and greatly improved cartilage repair.
Assuntos
Cartilagem Articular , Receptores de Hialuronatos , Ácido Hialurônico , Macrófagos , Animais , Receptores de Hialuronatos/metabolismo , Macrófagos/metabolismo , Macrófagos/efeitos dos fármacos , Coelhos , Cartilagem Articular/metabolismo , Cartilagem Articular/patologia , Ácido Hialurônico/metabolismo , Ácido Hialurônico/farmacologia , Proteínas da Matriz Extracelular/metabolismo , Polaridade Celular/efeitos dos fármacos , Polaridade Celular/fisiologia , Regeneração/efeitos dos fármacos , Regeneração/fisiologia , Inflamação/metabolismo , Inflamação/patologiaRESUMO
BACKGROUND: The recurrence of thyroid cancer poses challenges compounded by postoperative fibrosis and anatomic changes. By overcoming the limitations of current localizing dye techniques, indocyanine green-macroaggregated albumin-hyaluronic acid (ICG-MAA-HA) mixture dye promises improved localization. This study aimed to evaluate the efficacy and safety of the dye for recurrent thyroid cancer. METHODS: The nine patients in this study underwent surgery and postoperative ultrasonography. The dye was injected into recurrent lesions in all the patients preoperatively. During surgery, the lesions were confirmed with an imaging system before and after excision. If the lesion was unidentifiable with the naked eye, surgical excision was performed under the corresponding fluorescent guide. Side effects related to the dye injection and completeness of the surgery were evaluated. RESULTS: No side effects such as bleeding, skin tattooing, or pain during or after the dye injection were reported, and no discoloration occurred that interfered with the surgical field of view during surgery. In three cases (33.3 %), because it was difficult to localize metastatic lesions with the naked eye, the operation was successfully completed using an imaging system. The completeness of the surgical resection was confirmed by ultrasonography after an average of 5 months postoperatively. CONCLUSION: The study found that ICG-MAA-HA dye effectively located metastatic and recurrent thyroid cancer and had favorable results in terms of minimal procedural side effects and potential for assisting the surgeon. A large-scale multi-institutional study is necessary to prove the clinical significance regarding patient survival and disease control.
Assuntos
Verde de Indocianina , Neoplasias da Glândula Tireoide , Humanos , Ácido Hialurônico , Corantes , Neoplasias da Glândula Tireoide/diagnóstico por imagem , Neoplasias da Glândula Tireoide/cirurgia , Neoplasias da Glândula Tireoide/patologia , Albuminas , Biópsia de Linfonodo Sentinela/métodosRESUMO
BACKGROUND: Since cytokine receptor-like factor 1 (CRLF1) has been implicated in tissue regeneration, we hypothesized that CRLF1 released by mesenchymal stem cells can promote the repair of osteochondral defects. METHODS: The degree of a femoral osteochondral defect repair in rabbits after intra-articular injections of bone marrow-derived mesenchymal stem cells (BMSCs) that were transduced with empty adeno-associated virus (AAV) or AAV containing CRLF1 was determined by morphological, histological, and micro computer tomography (CT) analyses. The effects of CRLF1 on chondrogenic differentiation of BMSCs or catabolic events of interleukin-1beta-treated chondrocyte cell line TC28a2 were determined by alcian blue staining, gene expression levels of cartilage and catabolic marker genes using real-time PCR analysis, and immunoblot analysis of Smad2/3 and STAT3 signaling. RESULTS: Intra-articular injections of BMSCs overexpressing CRLF1 markedly improved repair of a rabbit femoral osteochondral defect. Overexpression of CRLF1 in BMSCs resulted in the release of a homodimeric CRLF1 complex that stimulated chondrogenic differentiation of BMSCs via enhancing Smad2/3 signaling, whereas the suppression of CRLF1 expression inhibited chondrogenic differentiation. In addition, CRLF1 inhibited catabolic events in TC28a2 cells cultured in an inflammatory environment, while a heterodimeric complex of CRLF1 and cardiotrophin-like Cytokine (CLC) stimulated catabolic events via STAT3 activation. CONCLUSION: A homodimeric CRLF1 complex released by BMSCs enhanced the repair of osteochondral defects via the inhibition of catabolic events in chondrocytes and the stimulation of chondrogenic differentiation of precursor cells.
Assuntos
Diferenciação Celular , Condrócitos , Condrogênese , Células-Tronco Mesenquimais , Animais , Coelhos , Células-Tronco Mesenquimais/metabolismo , Condrogênese/genética , Condrócitos/metabolismo , Receptores de Citocinas/metabolismo , Receptores de Citocinas/genética , Fêmur/patologia , Transdução de Sinais , Linhagem Celular , Transplante de Células-Tronco MesenquimaisRESUMO
The high interface resistance at the cathode-sulfide electrolyte interface is still a crucial drawback in an all-solid-state battery, unlike the initial expectation that the all-solid-state interface would enhance electrochemical stability by reducing side reactions at the interface. In this study, we examined the fundamental mechanism of unexpected reactions at the interface of LiNi0.8Co0.1Mn0.1O2 (NCM811) and argyrodite (Li6PS5Br0.5Cl0.5, LPSBC) sulfide solid electrolytes based on the combined method of multiscale simulations and electrochemical experiments. The high interface resistance originates from the formation of a passivating layer at the interface combined with irregular atomic and electronic structures, Li depletion, mutual element exchange, and mechanical contact loss between the oxide cathode and sulfide solid electrolyte. We also confirmed that these side reactions were suppressed by O substitutions to sulfide solid electrolyte (LPSOBC), and then the chemo-mechanical stability of the all-solid battery was enhanced by alleviating the side reactions at the interface. This study provides rational insights into the design of an interface for all-solid-state batteries.